OneMedNet Implements 1-for-10 Reverse Stock Split to Meet Nasdaq Listing Requirements

  • OneMedNet Corporation (Nasdaq: ONMD) will execute a 1-for-10 reverse stock split effective September 29, 2026.
  • The split reduces outstanding shares from ~59.3 million to ~5.93 million, maintaining total authorized shares.
  • Approved by stockholders on September 18, 2026, the move aims to comply with Nasdaq's minimum bid price requirement.
  • Trading under the same symbol (ONMD) with a new CUSIP number (68270C 202) begins September 29, 2026.

OneMedNet's reverse stock split is a strategic maneuver to avoid delisting, reflecting broader trends of distressed equities seeking compliance through share consolidation. The move underscores the pressure on small-cap healthcare data firms to maintain market access amid volatile trading conditions. With its iRWD platform and Palantir Foundry integration, OneMedNet's ability to monetize its 90M+ patient journeys will be critical in sustaining investor confidence.

Market Perception
How investors will react to the reduced share count and potential improved liquidity.
Nasdaq Compliance
Whether the reverse split will successfully maintain OneMedNet's listing status.
Operational Impact
The pace at which the company can leverage its data platform to drive revenue growth post-split.